Trending
- Switching to SC Dosing and Considering PRO Data for Amivantamab in NSCLC
- Isatuximab Combo Increases MRD Negativity in MRD-Positive Multiple Myeloma
- Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
- Validating a linked primary–secondary care data platform for analysis of non-specific cancer symptom pathways: a retrospective study
- CRISPR could help doctors attack blood cancer without destroying healthy cells
- FDA Clears TriNav Advance for Expanded Liver Embolization Access
- KIFC1 engages RUNX2/TGF-β signaling to promote lung cancer bone metastasis via disrupting bone homeostasis
- ‘A tumour the size of a football saved my life’
Friday, September 25